Bone Cash And Short Term Investments vs Total Assets Analysis

BBLGW Stock  USD 28.49  3.29  10.35%   
Bone Biologics financial indicator trend analysis is way more than just evaluating Bone Biologics Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bone Biologics Corp is a good investment. Please check the relationship between Bone Biologics Cash And Short Term Investments and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Cash And Short Term Investments vs Total Assets

Cash And Short Term Investments vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bone Biologics Corp Cash And Short Term Investments account and Total Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Bone Biologics' Cash And Short Term Investments and Total Assets is 0.76. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Assets in the same time period over historical financial statements of Bone Biologics Corp, assuming nothing else is changed. The correlation between historical values of Bone Biologics' Cash And Short Term Investments and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Bone Biologics Corp are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Cash And Short Term Investments i.e., Bone Biologics' Cash And Short Term Investments and Total Assets go up and down completely randomly.

Correlation Coefficient

0.76
Relationship DirectionPositive 
Relationship StrengthSignificant

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Bone Biologics Corp balance sheet. This account contains Bone Biologics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Bone Biologics Corp fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Assets

Total assets refers to the total amount of Bone Biologics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bone Biologics Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Bone Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bone Biologics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Selling General Administrative is likely to drop to about 2 M in 2024. Tax Provision is likely to drop to 2,078 in 2024
 2022 2023 2024 (projected)
Tax Provision3.2K3.7K2.1K
Interest Expense2.2M2.0M1.5M

Bone Biologics fundamental ratios Correlations

-0.39-0.21-0.36-0.42-0.39-0.39-0.340.240.67-0.63-0.51-0.56-0.74-0.39-0.37-0.2-0.61-0.080.7-0.52-0.44-0.230.03-0.370.21
-0.39-0.650.990.761.00.33-0.110.62-0.450.59-0.25-0.070.550.67-0.31-0.270.35-0.57-0.330.380.440.90.610.49-0.58
-0.21-0.65-0.68-0.34-0.660.120.56-0.99-0.02-0.120.890.730.08-0.430.820.340.210.81-0.210.01-0.15-0.8-0.78-0.280.7
-0.360.99-0.680.780.990.27-0.120.64-0.470.62-0.29-0.110.550.7-0.29-0.290.4-0.57-0.340.430.480.940.610.51-0.59
-0.420.76-0.340.780.760.330.390.28-0.570.660.040.050.660.920.060.190.55-0.16-0.440.550.590.640.080.64-0.38
-0.391.0-0.660.990.760.33-0.110.62-0.450.59-0.25-0.070.550.67-0.31-0.270.35-0.57-0.330.380.440.90.610.49-0.58
-0.390.330.120.270.330.330.28-0.22-0.290.310.440.570.330.20.120.00.380.19-0.570.090.030.12-0.020.030.15
-0.34-0.110.56-0.120.39-0.110.28-0.6-0.320.240.680.460.380.280.620.520.420.31-0.360.30.31-0.31-0.840.070.3
0.240.62-0.990.640.280.62-0.22-0.60.070.06-0.92-0.77-0.130.37-0.83-0.36-0.27-0.820.29-0.050.120.770.780.25-0.7
0.67-0.45-0.02-0.47-0.57-0.45-0.29-0.320.07-0.96-0.35-0.33-0.93-0.71-0.37-0.3-0.870.050.88-0.91-0.83-0.46-0.02-0.760.53
-0.630.59-0.120.620.660.590.310.240.06-0.960.230.260.930.740.280.220.86-0.14-0.840.910.860.610.140.79-0.54
-0.51-0.250.89-0.290.04-0.250.440.68-0.92-0.350.230.910.45-0.090.860.320.520.72-0.540.270.09-0.49-0.65-0.040.53
-0.56-0.070.73-0.110.05-0.070.570.46-0.77-0.330.260.910.43-0.120.70.180.530.6-0.610.21-0.08-0.3-0.38-0.170.48
-0.740.550.080.550.660.550.330.38-0.13-0.930.930.450.430.690.420.290.820.03-0.820.840.810.440.010.76-0.42
-0.390.67-0.430.70.920.670.20.280.37-0.710.74-0.09-0.120.69-0.050.330.55-0.25-0.50.650.720.660.150.8-0.65
-0.37-0.310.82-0.290.06-0.310.120.62-0.83-0.370.280.860.70.42-0.050.210.630.69-0.430.490.24-0.42-0.680.060.52
-0.2-0.270.34-0.290.19-0.270.00.52-0.36-0.30.220.320.180.290.330.210.120.33-0.260.220.23-0.33-0.530.3-0.13
-0.610.350.210.40.550.350.380.42-0.27-0.870.860.520.530.820.550.630.120.17-0.880.890.680.35-0.140.53-0.14
-0.08-0.570.81-0.57-0.16-0.570.190.31-0.820.05-0.140.720.60.03-0.250.690.330.17-0.14-0.03-0.22-0.69-0.55-0.10.69
0.7-0.33-0.21-0.34-0.44-0.33-0.57-0.360.290.88-0.84-0.54-0.61-0.82-0.5-0.43-0.26-0.88-0.14-0.73-0.59-0.310.06-0.50.25
-0.520.380.010.430.550.380.090.3-0.05-0.910.910.270.210.840.650.490.220.89-0.03-0.730.860.44-0.050.75-0.42
-0.440.44-0.150.480.590.440.030.310.12-0.830.860.09-0.080.810.720.240.230.68-0.22-0.590.860.51-0.010.89-0.57
-0.230.9-0.80.940.640.90.12-0.310.77-0.460.61-0.49-0.30.440.66-0.42-0.330.35-0.69-0.310.440.510.710.54-0.71
0.030.61-0.780.610.080.61-0.02-0.840.78-0.020.14-0.65-0.380.010.15-0.68-0.53-0.14-0.550.06-0.05-0.010.710.2-0.58
-0.370.49-0.280.510.640.490.030.070.25-0.760.79-0.04-0.170.760.80.060.30.53-0.1-0.50.750.890.540.2-0.66
0.21-0.580.7-0.59-0.38-0.580.150.3-0.70.53-0.540.530.48-0.42-0.650.52-0.13-0.140.690.25-0.42-0.57-0.71-0.58-0.66
Click cells to compare fundamentals

Bone Biologics Account Relationship Matchups

Bone Biologics fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding12.2K12.1K18.9K47.6K263.1K250.0K
Total Assets30.8K0.06.7M8.5M3.7M2.3M
Net Debt11.3M11.7M(6.7M)(7.5M)(3.0M)(2.9M)
Cash24.1K0.06.7M7.5M3.0M2.0M
Cash And Short Term Investments955.4K24.1K6.7M7.5M3.0M2.1M
Liabilities And Stockholders Equity30.8K13.7M6.7M8.5M3.7M3.5M
Total Current Assets30.8K0.06.7M8.5M3.7M2.3M
Other Current Liab535.6K1.0M(99.9K)2.5M110.1K104.6K
Total Current Liabilities578.4K13.7M99.9K2.5M831.4K789.8K
Total Stockholder Equity(11.9M)(13.7M)6.6M5.9M2.9M3.1M
Retained Earnings(67.0M)(68.9M)(70.5M)(72.0M)(80.9M)(76.9M)
Total Liab11.9M13.7M99.9K2.5M831.4K789.8K
Short Long Term Debt Total8.2M9M11.3M11.7M13.5M8.3M
Other Current Assets105.2K85.3K6.7K956.9K711.2K746.8K
Accounts Payable42.9K465.4K99.9K888.46360.7K202.9K
Non Current Liabilities Total8.2M0.011.3M12.2M99.9K888.46
Net Invested Capital(547.6K)(2.0M)6.6M5.9M2.9M2.1M
Net Working Capital(547.6K)(13.7M)6.6M5.9M2.9M3.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bone Stock Analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.